Capital Guardian Trust Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$61.5M |
| 2 |
Intel
INTC
|
+$40.1M |
| 3 |
Micron Technology
MU
|
+$38.6M |
| 4 |
ServiceNow
NOW
|
+$36.8M |
| 5 |
Adobe
ADBE
|
+$35.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$99.8M |
| 2 |
Mercado Libre
MELI
|
+$52.6M |
| 3 |
Accenture
ACN
|
+$51.6M |
| 4 |
Ryanair
RYAAY
|
+$33.9M |
| 5 |
Elanco Animal Health
ELAN
|
+$32.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.93% |
| 2 | Financials | 15.42% |
| 3 | Healthcare | 13.93% |
| 4 | Consumer Discretionary | 11.81% |
| 5 | Industrials | 10.34% |
No holdings matched the selected filter criteria.
Similar funds
Capital Guardian Trust's Q2 2019 Portfolio in Review
As of Q2 2019, Capital Guardian Trust held 322 positions worth $7.42B, down 1.3% from $7.53B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Capital Guardian Trust's Q2 2019 filing shows 16 new, 71 increased, 129 reduced and 94 closed positions. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 1,090,679 shares worth $47.8M. The largest sale was Apple, an estimated $99.8M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- Capital Guardian Trust's largest Q2 2019 buy was Biohaven Pharmaceutical Holding Company Ltd.: 1,090,679 shares worth $47.8M.
- Capital Guardian Trust added most to Intel in Q2 2019, an estimated $40.1M increase.
- Capital Guardian Trust's biggest Q2 2019 reduction was Apple, cutting an estimated $99.8M.
- Capital Guardian Trust fully exited GE Aerospace in Q2 2019, selling an estimated $24.6M.
- Capital Guardian Trust's ten largest holdings make up 18% of its $7.42B portfolio in Q2 2019.
- Capital Guardian Trust opened 16 new positions and closed 94 in Q2 2019.
- Capital Guardian Trust's portfolio value fell 1.3% quarter-over-quarter to $7.42B.
Based on Capital Guardian Trust's 13F filing for Q2 2019, filed 14 Aug 2019.